Abstract:A comprehensive investigation of the Hg 2+ coordination chemistry and 197m/g Hg radiolabeling capabilities of cyclen-based commercial chelators, namely, DOTA and DOTAM (aka TCMC), along with their bifunctional counterparts, p -SCN-Bn-DOTA and p -SCN-Bn-TCMC, was conducted to assess the suitability of these frameworks as bifunctional chelators for the 197m/g Hg 2+ theranostic pair. Radiolabeling studies revealed that TCMC and DOTA exhibited low radiochemical yields (0%–6%), even when subjected to harsh conditions (80°C) and high ligand concentrations (10 –4 M). In contrast, p -SCN-Bn-TCMC and p -SCN-Bn-DOTA demonstrated significantly higher 197m/g Hg radiochemical yields (100% ± 0.0% and 70.9% ± 1.1%, respectively) under the same conditions. The [ 197 m/g Hg]Hg- p -SCN-Bn-TCMC complex was kinetically inert when challenged against human serum and glutathione. To understand the differences in labeling between the commercial chelators and their bifunctional counterparts, non-radioactive nat Hg 2+ complexes were assessed using NMR spectroscopy and DFT calculations. The NMR spectra of Hg-TCMC and Hg- p -SCN-Bn-TCMC suggested binding of the Hg 2+ ion through the cyclen backbone framework. DFT studies indicated that binding of the Hg 2+ ion within the backbone forms a thermodynamically stable product. However, competition can form between isothiocyanate binding and binding through the macrocycle, which was experimentally observed. The isothiocyanate bound coordination product was dominant at the radiochemical scale as, in comparison, the macrocycle bound product was seen at the NMR scale, agreeing with the DFT result. Furthermore, a bioconjugate of TCMC (TCMC-PSMA) targeting prostate-specific membrane antigen was synthesized and radiolabeled, resulting in an apparent molar activity of 0.089 MBq/nmol. However, the complex demonstrated significant degradation over 24 h when exposed to human serum and glutathione. Subsequently, cell binding assays were conducted, revealing a K i value ranging from 19.0 to 19.6 nM. This research provides crucial insight into the effectiveness of current commercial chelators in the context of 197m/g Hg 2+ radiolabeling. It underscores the necessity for the development of specific and customized chelators to these unique "soft" radiometals to advance 197m/g Hg 2+ radiopharmaceuticals.

Tuning the Softness of the Pendant Arms and the Polyazamacrocyclic Backbone to Chelate the 203 Pb/ 212 Pb Theranostic Pair

Preparation of A Macroporous Silica-Based Multidentate Soft-Ligand Material and Its Application in the Adsorption of Palladium and the Others

Incorporation of Carboxylate Pendant Arms into 18‐Membered Macrocycles: Effects on [nat/203Pb]Pb(II) Complexation

The H2S x macropa Series: Increasing the Chemical Softness of H2macropa with Sulfur Atoms to Chelate Radiometals [213Bi]Bi3+ and [203Pb]Pb2+ for Radiopharmaceutical Applications

Exploring the use of rigid 18-membered macrocycles with amide pendant arms for Pb(II)-based radiopharmaceuticals

Double-Armed 18- and 21-Membered Macrocycles as Potential Chelators for Lead and Bismuth Radiopharmaceuticals

Theoretical Study of Metal-Ligand Interactions in Lead Complexes with Radiopharmaceutical Interest

Unveiling the Potential of Sulfur-Rich Macrocyclic Chelators Against Cadmium Poisoning

Development of Thiacrown Ligands for Encapsulation of Mercury-197m/g into Radiopharmaceuticals

Exploration of commercial cyclen-based chelators for mercury-197 m/g incorporation into theranostic radiopharmaceuticals

Chelators for Radioimmunotherapy: I. NMR and Ab Initio Calculation Studies on 1,4,7,10-Tetra(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO4Pr) and 1,4,7-Tris(carboxymethyl)-10-(carboxyethyl)-1,4,7,10-tetraazacyclododecane (DO3A1Pr)

Boosting Bismuth(III) Complexation for Targeted α‐Therapy (TAT) Applications with the Mesocyclic Chelating Agent AAZTA

Is Smaller Better? Cu2+/Cu+ Coordination Chemistry and Copper-64 Radiochemical Investigation of a 1,4,7-Triazacyclononane-Based Sulfur-Rich Chelator

Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetraacetic Acid (DOTA) and Its Analogues

Charting the Coordinative Landscape of the 18 F-Sc/ 44 Sc/ 177 Lu triad with the Tri-aza-cyclononane (tacn) Scaffold.

Tetravalent Terbium Chelates: Stability Enhancement and Property Tuning

Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair

Structural And Thermodynamics Studies On Polyaminophosphonate Ligands For Uranyl Decorporation

Yttrium-90 chelation properties of tetraazatetraacetic acid macrocycles, diethylenetriaminepentaacetic acid analogues, and a novel terpyridine acyclic chelator

Exploring the Spatial Arrangement of Simple 18-Membered Hexaazatetraamine Macrocyclic Ligands in Their Metal Complexes

2,6-Bis(5-( tert -butyl)-1 H -pyrazol-3-yl)pyridine: Effects of the Peripheral Aliphatic Side Chain on the Coordination of Actinides(III) and Lanthanides(III)